BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 30363393)

  • 1. Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.
    Mestre TA; Forjaz MJ; Mahlknecht P; Cardoso F; Ferreira JJ; Reilmann R; Sampaio C; Goetz CG; Cubo E; Martinez-Martin P; Stebbins GT;
    Mov Disord Clin Pract; 2018; 5(2):111-117. PubMed ID: 30363393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rating scales for behavioral symptoms in Huntington's disease: Critique and recommendations.
    Mestre TA; van Duijn E; Davis AM; Bachoud-Lévi AC; Busse M; Anderson KE; Ferreira JJ; Mahlknecht P; Tumas V; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2016 Oct; 31(10):1466-1478. PubMed ID: 27296904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rating scales for cognition in Huntington's disease: Critique and recommendations.
    Mestre TA; Bachoud-Lévi AC; Marinus J; Stout JC; Paulsen JS; Como P; Duff K; Sampaio C; Goetz CG; Cubo E; Stebbins GT; Martinez-Martin P;
    Mov Disord; 2018 Feb; 33(2):187-195. PubMed ID: 29278291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rating Scales and Performance-based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations.
    Mestre TA; Busse M; Davis AM; Quinn L; Rodrigues FB; Burgunder JM; Carlozzi NE; Walker F; Ho AK; Sampaio C; Goetz CG; Cubo E; Martinez-Martin P; Stebbins GT;
    Mov Disord Clin Pract; 2018; 5(4):361-372. PubMed ID: 30363510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Longitudinal assessment of the Unified Huntington's Disease Rating Scale (UHDRS) and UHDRS-For Advanced Patients (UHDRS-FAP) in patients with late stage Huntington's disease.
    Winder JY; Achterberg WP; Gardiner SL; Roos RAC
    Eur J Neurol; 2019 May; 26(5):780-785. PubMed ID: 30576046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fatigue rating scales critique and recommendations by the Movement Disorders Society task force on rating scales for Parkinson's disease.
    Friedman JH; Alves G; Hagell P; Marinus J; Marsh L; Martinez-Martin P; Goetz CG; Poewe W; Rascol O; Sampaio C; Stebbins G; Schrag A
    Mov Disord; 2010 May; 25(7):805-22. PubMed ID: 20461797
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predicting Severity of Huntington's Disease With Wearable Sensors.
    Scheid BH; Aradi S; Pierson RM; Baldassano S; Tivon I; Litt B; Gonzalez-Alegre P
    Front Digit Health; 2022; 4():874208. PubMed ID: 35445206
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Task force report on scales to assess dyskinesia in Parkinson's disease: critique and recommendations.
    Colosimo C; Martínez-Martín P; Fabbrini G; Hauser RA; Merello M; Miyasaki J; Poewe W; Sampaio C; Rascol O; Stebbins GT; Schrag A; Goetz CG
    Mov Disord; 2010 Jul; 25(9):1131-42. PubMed ID: 20310033
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of Life in Huntington's Disease: Critique and Recommendations for Measures Assessing Patient Health-Related Quality of Life and Caregiver Quality of Life.
    Mestre TA; Carlozzi NE; Ho AK; Burgunder JM; Walker F; Davis AM; Busse M; Quinn L; Rodrigues FB; Sampaio C; Goetz CG; Cubo E; Martinez-Martin P; Stebbins GT;
    Mov Disord; 2018 May; 33(5):742-749. PubMed ID: 29570848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tongue force analysis assesses motor phenotype in premanifest and symptomatic Huntington's disease.
    Reilmann R; Bohlen S; Klopstock T; Bender A; Weindl A; Saemann P; Auer DP; Ringelstein EB; Lange HW
    Mov Disord; 2010 Oct; 25(13):2195-202. PubMed ID: 20645403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dystonia-predominant adult-onset Huntington disease: association between motor phenotype and age of onset in adults.
    Louis ED; Anderson KE; Moskowitz C; Thorne DZ; Marder K
    Arch Neurol; 2000 Sep; 57(9):1326-30. PubMed ID: 10987900
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The unified Huntington's Disease Rating Scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Dec; 28(14):1995-2001. PubMed ID: 24123464
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment Scales for Patients with Advanced Huntington's Disease: Comparison of the UHDRS and UHDRS-FAP.
    Winder JY; Achterberg WP; Marinus J; Gardiner SL; Roos RAC
    Mov Disord Clin Pract; 2018; 5(5):527-533. PubMed ID: 30515443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unified Huntington's disease rating scale for advanced patients: validation and follow-up study.
    Youssov K; Dolbeau G; Maison P; Boissé MF; Cleret de Langavant L; Roos RA; Bachoud-Lévi AC
    Mov Disord; 2013 Oct; 28(12):1717-23. PubMed ID: 24166899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interrater Reliability of the Unified Huntington's Disease Rating Scale-Total Motor Score Certification.
    Winder JY; Roos RAC; Burgunder JM; Marinus J; Reilmann R
    Mov Disord Clin Pract; 2018; 5(3):290-295. PubMed ID: 30363437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and genetic characteristics in patients with Huntington's disease from China.
    Yang J; Chen K; Wei Q; Chen Y; Cao B; Burgunder JM; Shang HF
    Neurol Res; 2016 Oct; 38(10):916-20. PubMed ID: 27483361
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unawareness of dyskinesias in Parkinson's and Huntington's diseases.
    Vitale C; Pellecchia MT; Grossi D; Fragassi N; Cuomo T; Di Maio L; Barone P
    Neurol Sci; 2001 Feb; 22(1):105-6. PubMed ID: 11487181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluating motor progression of juvenile-onset Huntington's Disease: An Enroll-HD analysis.
    Nopoulos S; Reasoner EE; Ogilvie AC; Killoran A; Schultz JL
    Parkinsonism Relat Disord; 2024 Feb; 119():105954. PubMed ID: 38142629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of the Huntington's Disease like 2 and Huntington's Disease Clinical Phenotypes.
    Anderson DG; Ferreira-Correia A; Rodrigues FB; Aziz NA; Carr J; Wild EJ; Margolis RL; Krause A
    Mov Disord Clin Pract; 2019 Apr; 6(4):302-311. PubMed ID: 31061838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of involuntary choreatic movements in Huntington's disease--toward objective and quantitative measures.
    Reilmann R; Bohlen S; Kirsten F; Ringelstein EB; Lange HW
    Mov Disord; 2011 Oct; 26(12):2267-73. PubMed ID: 21661053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.